MSVZX
Price
$8.26
Change
-$0.70 (-7.81%)
Updated
Apr 3 closing price
Net Assets
58.16M
VSCAX
Price
$20.55
Change
-$1.97 (-8.75%)
Updated
Apr 3 closing price
Net Assets
6.34B
Ad is loading...

MSVZX vs VSCAX

Header iconMSVZX vs VSCAX Comparison
Open Charts MSVZX vs VSCAXBanner chart's image
MassMutual Small Company Val I
Price$8.26
Change-$0.70 (-7.81%)
VolumeN/A
Net Assets58.16M
Invesco Small Cap Value A
Price$20.55
Change-$1.97 (-8.75%)
VolumeN/A
Net Assets6.34B
MSVZX vs VSCAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSVZX vs. VSCAX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSVZX is a Hold and VSCAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VSCAX has more cash in the bank: 6.35B vs. MSVZX (58.2M). MSVZX pays higher dividends than VSCAX: MSVZX (1.54) vs VSCAX (0.37). MSVZX was incepted earlier than VSCAX: MSVZX (14 years) vs VSCAX (26 years). VSCAX (1.12) is less costly to investors than MSVZX (1.06). MSVZX is a more actively managed with annual turnover of: 57.00 vs. VSCAX (40.00). MSVZX has a lower initial minimum investment than VSCAX: MSVZX (0) vs VSCAX (1000). MSVZX annual gain was more profitable for investors over the last year : 0.22 vs. VSCAX (-1.20). VSCAX return over 5 years is better than : 216.20 vs. MSVZX (70.03).
MSVZXVSCAXMSVZX / VSCAX
Total Expense Ratio0.861.1277%
Annual Report Gross Expense Ratio1.061.1295%
Fund Existence14 years26 years-
Gain YTD-6.861-4.211163%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets58.2M6.35B1%
Annual Yield % from dividends1.540.37421%
Returns for 1 year0.22-1.20-18%
Returns for 3 years-15.9113.84-115%
Returns for 5 years70.03216.2032%
Returns for 10 years-34.279.77-351%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ICTTX12.85N/A
N/A
ICON Health and Information Tech Inv
BRXSX13.75N/A
N/A
MFS Blended Research Intl Eq R2
DGEYX20.42N/A
N/A
BNY Mellon Global Emerging Mkts - Y
GAOTX20.20N/A
N/A
JPMorgan Global Allocation R3
CBFFX36.62-0.68
-1.82%
American Funds Global Balanced 529F1